Document is current
Any future updates will be listed below
-
Authors
Mohr, Luis
Lishewski, Philipp
Schymalla, Markus
Tas, Kerem Tuna
Smalec, Edgar
Engenhart-Cabillic, Rita
Kemmling, André
Schulze, Maximilian
Elsayad, Khaled
Eberle, Fabian
Nimsky, Christopher
Vorwerk, Hilke https://orcid.org/0000-0001-7542-683X
Zink, Klemens
Gawish, Ahmed
Adeberg, Sebastian
-
Funding
Funding for this research was provided by:
Philipps-Universität Marburg
- License Information
-
More Information
Article History
Received: 8 April 2025
Accepted: 8 August 2025
First Online: 26 September 2025
Conflict of interest
: L. Mohr, P. Lishewski, M. Schymalla, K.T. Tas, E. Smalec, R. Engenhart-Cabillic, A. Kemmling, M. Schulze, K. Elsayad, F. Eberle, C. Nimsky, H. Vorwerk, K. Zink, A. Gawish and S. Adeberg declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. S. Adeberg Honoraria/travel reimbursement Accuray Inc., AstraZeneca GmbH, Servier, Bristol Myers Squibb GmbH & Co., MSD, Novocure GmbH, Merck KGaA, Fakultät Heidelberg, Fakultät Marburg, Sanofi Genzyme, S. Adeberg: Research cooperations Novocure GmbH. SA: Scientific Advisory Accuray Inc., Sanofi Genzyme, Servier, Novartis, Novocure GmbH, Merck KGaA.
